JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Tunneling Control: Competition between 6π-Electrocyclization and [1,5]H-Sigmatropic Shift Reactions in Tetrahydro-1H-cyclobuta[e]indene Derivatives.

Direct dynamics calculation using canonical variational transtition state theory (CVT) inclusive of small curvature tunneling (SCT) reveals the influential role of quantum mechanical tunneling (QMT) for 2,2a,5,7b-tetrahydro-1H-cyclobuta[e]indene derivatives (2a-2j) in governing their product selectivity. 2a-2j follow two distinct reaction channels, namely, 6π-electrocyclization (2 → 3) and [1,5]H-sigmatropic shift (2 → 4), among which the activation barrier is higher for [1,5]H-shift (2 → 4), thereby favoring the kinetically controlled product (3a-3j) as anticipated. However, SCT calculations show that a narrower barrier and smaller mass of participating atoms make QMT more pronounced for [1,5]H-shift reaction despite its higher activation energy, which results in a competition between kinetic controlled (2 → 3) and tunneling controlled (2 → 4) products. At low temperature (T ≤ 170 K), when QMT is the dominant pathway, the tunneling controlled product (4a-4j) is formed exclusively. As the reaction temperature increases, the role of QMT becomes less prominent and eventually gets kinetically controlled at room temperature. Nevertheless, QMT strongly tunes the product ratio at ambient temperatures by favoring the [1,5]H-shift reaction over 6π-electrocyclization. For 2a, k[1,5]H-shift :k6π-electrocyclization increases from 1:13 at CVT level to 1:2 at CVT+SCT level for room temperature.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app